← All trials
NCT02719977
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 16, 2016
- Primary completion
- Apr 1, 2018
- Completion date
- Apr 1, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 98
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Canadian Cancer Trials GroupLead sponsor
- University of OttawaStudy chair
- British Columbia Cancer AgencyStudy chair
- Senhwa Biosciences, Inc.Collaborator
- Stand Up To CancerCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.